Fineotex Chemical Q1 FY27 Total Income Surges 164% to ₹386.7 Cr, PAT Up 93%
Fineotex Chemical Limited reported Q1 FY27 Total Income of ₹386.7 crore, a 164% YoY increase. Consolidated EBITDA rose 135% to ₹59.1 crore, and PAT increased 93% to ₹48.2 crore. The company commissioned a major capacity expansion at its Texas facility, increasing capacity to 1,48,000 MTPA.
The substantial financial growth and strategic operational expansions indicate a strong positive impact on the company's performance and future prospects.
The company reported significant year-on-year growth in Total Income, EBITDA, and PAT, along with operational highlights like capacity expansion and successful integration of acquisitions.
Fineotex Chemical Limited (FCL) has announced its unaudited financial results for the first quarter ended June 30th, 2026 (Q1 FY27). The company reported a significant surge in Total Income from Operations, which increased by 164.48% year-on-year to ₹386.72 crore. Consolidated EBITDA saw a rise of 134.69% to ₹59.14 crore, with EBITDA margin at 15.70%. Profit After Tax (PAT) grew by 92.67% year-on-year to ₹48.21 crore. The company also highlighted improvements in Gross Profit, which increased by 190.25% to ₹133.40 crore, with Gross Margin improving to 35.42%. The Return on Invested Capital (ROIC) stood at 33.06% and Return on Capital Employed (ROCE) at 25.56%, with working capital at 72 days.
Operationally, FCL reported successful integration of CrudeChem Technologies Group, enhancing its presence in Oil & Gas specialty chemicals. The company also commissioned a major capacity expansion at its Texas facility, increasing total manufacturing capacity to approximately 1,48,000 MTPA. FCL successfully managed higher raw material costs through effective pricing, preserving healthy blended margins. The company continues to explore inorganic growth opportunities and expand across Textile, Oil & Gas, Water Treatment, FMCG, and Cleaning & Hygiene segments.
Mr. Sanjay Tibrewala, Executive Director and CFO, attributed the strong start to FY27 to the successful integration of the oilfield specialty chemicals business, which has significantly enhanced the company's global oil & gas chemicals market presence. Ms. Aarti Jhunjhunwala, Executive Director, noted the strong performance of the core domestic business, healthy demand across key end-user industries, and the strength of the diversified specialty chemicals portfolio. She also emphasized the successful commissioning of the U.S. manufacturing facility expansion and the focus on expanding global footprint and enhancing product offerings.
What to do with a filing like this
Fineotex Chemical Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fineotex Chemical Limited. Read the original for the full detail.